Moreover, we have shown that the observed increase in systemic ADAM10 level in type 2 diabetes was accompanied by changes in its substrate concentration, and serum ADAM10 level correlated with sLOX‐1 in our study. Here, OLR1 is linked to type 2 diabetes mellitus.